Hyperandrogenism and malignant degeneration of hepatic adenomas in the setting of Abernethy malformation

Matthews, 1985, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883 Abernethy, 1797, Account of two instances of uncommon formation in the viscera of the human body, Med Facts Obs, 7, 100 Morgan, 1994, Congenital absence of the portal vein: Two cases and a proposed classification system for portasystemic vascular anomalies, J Pediatr Surg, 29, 1239, 10.1016/0022-3468(94)90812-5 Alonso-Gamarra, 2011, Clinical and radiologic manifestations of congenital extrahepatic portosystemic shunts: a comprehensive review, Radiogr Rev Publ Radiol Soc N Am Inc, 31, 707 Ghuman, 2016, The Abernethy malformation—myriad imaging manifestations of a single entity, Indian J Radiol Imaging, 26, 364, 10.4103/0971-3026.190420 Ikeda, 1999, Successful coil embolization in an infant with congenital intrahepatic portosystemic shunts, J Pediatr Surg, 34, 1031, 10.1016/S0022-3468(99)90785-6 Fu, 2016, Congenital extrahepatic portosystemic shunt: an underdiagnosed but treatable cause of hepatopulmonary syndrome, Eur J Pediatr, 175, 195, 10.1007/s00431-015-2623-4 Kim, 2012, Clinical features of congenital portosystemic shunt in children, Eur J Pediatr, 171, 395, 10.1007/s00431-011-1564-9 Lautz, 2011, Management and classification of type II congenital portosystemic shunts, J Pediatr Surg, 46, 308, 10.1016/j.jpedsurg.2010.11.009 Kanamori, 2003, Congenital extrahepatic portocaval shunt (Abernethy type 2), huge liver mass, and patent ductus arteriosus–a case report of its rare clinical presentation in a young girl, J Pediatr Surg, 38, E15, 10.1053/jpsu.2003.50153 Satoh, 2001, Two hyperandrogenic adolescent girls with congenital portosystemic shunt, Eur J Pediatr, 160, 307, 10.1007/s004310000539 Sokollik, 2013, Congenital portosystemic shunt: characterization of a multisystem disease, J Pediatr Gastroenterol Nutr, 56, 675, 10.1097/MPG.0b013e31828b3750 Uchino, 1999, The long-term prognosis of congenital portosystemic venous shunt, J Pediatr, 135, 254, 10.1016/S0022-3476(99)70031-4 Benedict, 2017, Congenital Extrahepatic Portosystemic Shunt (Abernethy Malformation Type Ib) With Associated Hepatocellular Carcinoma: Case Report and Literature Review, Pediatr Dev Pathol Off J Soc Pediatr Pathol Paediatr Pathol Soc, 20, 354, 10.1177/1093526616686458 Virdis, 2018, Hepatocellular carcinoma in abernethy malformation: a rare occurrence of congenital complete portosystemic shunt, J Vasc Interv Radiol JVIR, 29, 1775, 10.1016/j.jvir.2018.07.014 Christou, 2018, Stepwise management of hepatocellular carcinoma associated with Abernethy syndrome, Clin Case Rep, 6, 930, 10.1002/ccr3.1384 Rajeswaran, 2020, Abernethy Malformations: Evaluation and Management of Congenital Portosystemic Shunts, J Vasc Interv Radiol JVIR, 31, 788, 10.1016/j.jvir.2019.08.007 Dunaif, 1996, The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome, J Clin Endocrinol Metab, 81, 3299 Munir, 2004, Insulin augmentation of 17alpha-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells, Endocrinology, 145, 175, 10.1210/en.2003-0329 Kasuga, 1980, Ovarian steroidogenesis in Japanese patients with polycystic ovary syndrome, Endocrinol Jpn, 27, 541, 10.1507/endocrj1954.27.541 Kanazawa, 2015, The classification based on intrahepatic portal system for congenital portosystemic shunts, J Pediatr Surg, 50, 688, 10.1016/j.jpedsurg.2015.01.009